GlassScriptPhysician profile
Harshini Dhananjay
NPI 1225266398
$1,955.28
in general payments reported to CMS, 2019-2025
13 companies · $441 in 2025
The $441 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $127 · 2021: $488 · 2022: $406 · 2023: $37.92 · 2024: $455 · 2025: $441.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $934.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $934.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $738.61 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Kyphon Express II Kyphopak Tray |
| Boston Scientific Corporation | $396.19 | 2021-2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
| Nevro Corp. | $151.53 | 2020-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $124.63 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $101.24 | 2020-2021 | |
| Abbvie INC. | $90.07 | 2022 | |
| Ibsa Pharma INC. | $84.63 | 2020-2025 | Flector, Licart, Tirosint |
| Collegium Pharmaceutical, INC. | $72.39 | 2022-2023 | Xtampza |
| Scilex Pharmaceuticals INC. | $58.03 | 2020-2022 | |
| Amgen INC. | $56.70 | 2021-2022 | |
| Abbott Laboratories | $41.27 | 2021-2025 | Proclaim |
| Bioventus LLC | $26.45 | 2020-2021 | |
| Allergan, INC. | $13.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harshini Dhananjay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.